Kewaunee Scientific (KEQU) SVP awarded 2,628 FY27 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Noble Ryan S. reported acquisition or exercise transactions in this Form 4 filing.

Kewaunee Scientific reported that senior vice president of Sales & Marketing Development Ryan S. Noble received a grant of 2,628 Restricted Stock Units (RSUs) for FY27 on June 24, 2026. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 30, 2027, subject to his continued employment with the company. Following this compensation-related award, Noble holds 2,628 RSUs linked to Kewaunee Scientific common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Noble Ryan S.

Role SVP, Sales & Marketing Dev

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units FY27	2,628	$0.00	--

Holdings After Transaction: Restricted Stock Units FY27 — 2,628 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Key Figures

RSUs granted: 2,628 units Underlying common shares: 2,628 shares Post-grant RSU holdings: 2,628 units +2 more

5 metrics

RSUs granted 2,628 units Restricted Stock Units FY27 granted to Ryan S. Noble

Underlying common shares 2,628 shares Each RSU represents one share of common stock

Post-grant RSU holdings 2,628 units Total RSUs held following this transaction

Vesting schedule 3 equal annual installments Beginning June 30, 2027, subject to continued employment

Transaction date June 24, 2026 Grant date of FY27 Restricted Stock Units

Key Terms

Restricted Stock Units, contingent right, vest, grant/award acquisition

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of the Company's common stock"

vest financial

"The restricted stock units shall vest in three equal annual installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

grant/award acquisition financial

"transaction_action: grant/award acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 04:33 PM Accepted by SEC EDGAR 06/25/2026 - 04:33 PM

FAQ

What insider transaction did KEQU report for Ryan S. Noble on this Form 4?

KEQU reported that Ryan S. Noble received a grant of 2,628 Restricted Stock Units. These units are a form of equity compensation that may convert into common shares over time, aligning his interests with long-term company performance.

How many Restricted Stock Units did KEQU grant to Ryan S. Noble?

Kewaunee Scientific granted 2,628 Restricted Stock Units to Ryan S. Noble. Each unit can settle into one share of common stock if vesting conditions are met, providing potential future ownership rather than immediate cash compensation.

What are the vesting terms of Ryan S. Noble’s KEQU FY27 RSU grant?

The FY27 RSUs granted to Ryan S. Noble vest in three equal annual installments starting June 30, 2027. Vesting is contingent on his continued employment, encouraging longer-term retention and alignment with the company’s multi‑year performance.

Does the KEQU Form 4 show any stock sales by Ryan S. Noble?

The Form 4 for KEQU shows only an acquisition of 2,628 Restricted Stock Units by Ryan S. Noble. It does not report any open‑market sales or dispositions, reflecting a compensation grant rather than trading activity in existing holdings.

What does each KEQU Restricted Stock Unit represent in this Form 4?

Each Restricted Stock Unit described in the KEQU filing represents a contingent right to receive one share of Kewaunee Scientific common stock. Actual share delivery depends on vesting, which is tied to continued employment over the three‑year schedule.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Noble Ryan S.

(Last)

(First)

(Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE

NORTH CAROLINA

28677

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Sales & Marketing Dev

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units FY27	⁽¹⁾	06/24/2026		A		2,628		⁽²⁾	⁽²⁾	Common Stock	2,628	$0	2,628	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR